PAR2 antagonists: anti-inflammatory agents?

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1226, 2000-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gonadotropin-Releasing Hormone Antagonists for Assisted Reproductive Techniques: Are There Clinical Differences Between Agents?

By Griesinger G. Felberbaum R.E. Schultze-Mosgau A. Diedrich K.

Drugs, Vol. 64, Iss. 6, 2004-01 ,pp. : 563-575

Adis International

Access to resources Recommend Favorite

Elaboration of New Anti-Inflammatory Agents Using Pharmacophore Based 3D QSAR of 4, 5-Diaryl Imidazoline as P2X7 Receptor Antagonists

Letters in Drug Design & Discovery, Vol. 9, Iss. 2, 2012-02 ,pp. : 185-198

Bentham Science Publishers

Access to resources Recommend Favorite

By Schifilliti Daniela

CNS Drugs, Vol. 24, Iss. 11, 2010-11 ,pp. : 893-907

Adis International

Access to resources Recommend Favorite

Can statins operate as neuroprotective agents?

Inpharma, Vol. 1, Iss. 1305, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

COX-2 Selective Nonsteroidal Anti-Inflammatory Drugs: Do They Really Offer Any Advantages?

By Jackson L.M. Hawkey C.J.

Drugs, Vol. 59, Iss. 6, 2000-06 ,pp. : 1207-1216

Adis International

Access to resources Recommend Favorite